Literature DB >> 22910322

A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells.

Erin E Hillhouse1, Sylvie Lesage.   

Abstract

Double negative T cells that lack the expression of both CD4 and CD8 T cell co-receptors exhibit a most unique antigen-specific immunoregulatory potential first described over a decade ago. Due to their immunoregulatory function, this rare T cell population has been studied in both mice and humans for their contribution to peripheral tolerance and disease prevention. Consequently, double negative cells are gaining interest as a potential cellular therapeutic. Herein, we review the phenotype and function of double negative T cells with emphasis on their capacity to induce antigen-specific immune tolerance. While the phenotypic and functional similarities between double negative T cells identified in mouse and humans are highlighted, we also call attention to the need for a specific marker of double negative T cells, which will facilitate future studies in humans. Altogether, due to their unique properties, double negative T cells present a promising therapeutic potential in the context of various disease settings.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22910322     DOI: 10.1016/j.jaut.2012.07.010

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  43 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  Elevated double negative T cells in pediatric autoimmunity.

Authors:  James A Tarbox; Molly P Keppel; Nermina Topcagic; Charles Mackin; Miriam Ben Abdallah; Kevin W Baszis; Andrew J White; Anthony R French; Megan A Cooper
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

3.  Distinctive Leukocyte Subpopulations According to Organ Type in Cynomolgus Macaques.

Authors:  Jonah S Zitsman; Paula Alonso-Guallart; Christopher Ovanez; Yojiro Kato; Joanna F Rosen; Joshua I Weiner; Raimon Duran-Struuck
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

4.  Renal double negative T cells: unconventional cells in search of a function.

Authors:  Raphael A Nemenoff; Emily K Kleczko; Katharina Hopp
Journal:  Ann Transl Med       Date:  2019-12

5.  Idd13 is involved in determining immunoregulatory DN T-cell number in NOD mice.

Authors:  V Dugas; A Liston; E E Hillhouse; R Collin; G Chabot-Roy; A-N Pelletier; C Beauchamp; K Hardy; S Lesage
Journal:  Genes Immun       Date:  2014-01-16       Impact factor: 2.676

6.  Association of Epstein-Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation.

Authors:  Z Bian; J Liu; L-P Xu; Y-J Chang; Y Wang; X-H Zhang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2016-10-31       Impact factor: 5.483

Review 7.  DNA methylation in systemic lupus erythematosus.

Authors:  Christian M Hedrich; Katrin Mäbert; Thomas Rauen; George C Tsokos
Journal:  Epigenomics       Date:  2016-11-25       Impact factor: 4.778

8.  Unusual selection and peripheral homeostasis for immunoregulatory CD4(-)  CD8(-) T cells.

Authors:  Véronique Dugas; Geneviève Chabot-Roy; Claudine Beauchamp; Fanny Guimont-Desrochers; Erin E Hillhouse; Adrian Liston; Sylvie Lesage
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

9.  Double-negative T resident memory cells of the lung react to influenza virus infection via CD11c(hi) dendritic cells.

Authors:  K Neyt; C H GeurtsvanKessel; B N Lambrecht
Journal:  Mucosal Immunol       Date:  2015-09-16       Impact factor: 7.313

10.  Evidence of genetic epistasis in autoimmune diabetes susceptibility revealed by mouse congenic sublines.

Authors:  Roxanne Collin; Véronique Dugas; Adam-Nicolas Pelletier; Geneviève Chabot-Roy; Sylvie Lesage
Journal:  Immunogenetics       Date:  2021-03-23       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.